Adjustable Maintenance Dosing with Budesonide/Formoterol Reduces Asthma Exacerbations Compared with Traditional Fixed Dosing: A Five-Month Multicentre Canadian Study

BACKGROUND: Adjustable maintenance dosing with budesonide/formoterol in a single inhaler (Symbicort, AstraZeneca, Lund, Sweden) may provide a convenient means of maintaining asthma control with the minimum effective medication level.

Saved in:
Bibliographic Details
Main Authors: J Mark FitzGerlad, Malcolm R Sears, Louis-Philippe Boulet, Allan B Becker, Andrew R McIvor, Pierre Ernst, Natasha M Smiljanic-Georgijev, Joanna SM Lee
Format: Article
Language:English
Published: Wiley 2003-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2003/298039
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565836463734784
author J Mark FitzGerlad
Malcolm R Sears
Louis-Philippe Boulet
Allan B Becker
Andrew R McIvor
Pierre Ernst
Natasha M Smiljanic-Georgijev
Joanna SM Lee
author_facet J Mark FitzGerlad
Malcolm R Sears
Louis-Philippe Boulet
Allan B Becker
Andrew R McIvor
Pierre Ernst
Natasha M Smiljanic-Georgijev
Joanna SM Lee
author_sort J Mark FitzGerlad
collection DOAJ
description BACKGROUND: Adjustable maintenance dosing with budesonide/formoterol in a single inhaler (Symbicort, AstraZeneca, Lund, Sweden) may provide a convenient means of maintaining asthma control with the minimum effective medication level.
format Article
id doaj-art-0f7224ca82f745c4a92f42cd36e7378b
institution Kabale University
issn 1198-2241
language English
publishDate 2003-01-01
publisher Wiley
record_format Article
series Canadian Respiratory Journal
spelling doaj-art-0f7224ca82f745c4a92f42cd36e7378b2025-02-03T01:06:15ZengWileyCanadian Respiratory Journal1198-22412003-01-0110842743410.1155/2003/298039Adjustable Maintenance Dosing with Budesonide/Formoterol Reduces Asthma Exacerbations Compared with Traditional Fixed Dosing: A Five-Month Multicentre Canadian StudyJ Mark FitzGerlad0Malcolm R Sears1Louis-Philippe Boulet2Allan B Becker3Andrew R McIvor4Pierre Ernst5Natasha M Smiljanic-Georgijev6Joanna SM Lee7University of British Columbia, Vancouver, British Columbia, CanadaMcMaster University, Hamilton, Ontario, CanadaLaval University, Quebec City, Quebec, CanadaUniversity of Manitoba, Winnipeg, Manitoba, CanadaDalhousie University, Halifax, Nova Scotia, CanadaMcGill University, Montreal, Quebec, CanadaAstraZeneca Canada, Mississauga, Ontario, CanadaAstraZeneca Canada, Mississauga, Ontario, CanadaBACKGROUND: Adjustable maintenance dosing with budesonide/formoterol in a single inhaler (Symbicort, AstraZeneca, Lund, Sweden) may provide a convenient means of maintaining asthma control with the minimum effective medication level.http://dx.doi.org/10.1155/2003/298039
spellingShingle J Mark FitzGerlad
Malcolm R Sears
Louis-Philippe Boulet
Allan B Becker
Andrew R McIvor
Pierre Ernst
Natasha M Smiljanic-Georgijev
Joanna SM Lee
Adjustable Maintenance Dosing with Budesonide/Formoterol Reduces Asthma Exacerbations Compared with Traditional Fixed Dosing: A Five-Month Multicentre Canadian Study
Canadian Respiratory Journal
title Adjustable Maintenance Dosing with Budesonide/Formoterol Reduces Asthma Exacerbations Compared with Traditional Fixed Dosing: A Five-Month Multicentre Canadian Study
title_full Adjustable Maintenance Dosing with Budesonide/Formoterol Reduces Asthma Exacerbations Compared with Traditional Fixed Dosing: A Five-Month Multicentre Canadian Study
title_fullStr Adjustable Maintenance Dosing with Budesonide/Formoterol Reduces Asthma Exacerbations Compared with Traditional Fixed Dosing: A Five-Month Multicentre Canadian Study
title_full_unstemmed Adjustable Maintenance Dosing with Budesonide/Formoterol Reduces Asthma Exacerbations Compared with Traditional Fixed Dosing: A Five-Month Multicentre Canadian Study
title_short Adjustable Maintenance Dosing with Budesonide/Formoterol Reduces Asthma Exacerbations Compared with Traditional Fixed Dosing: A Five-Month Multicentre Canadian Study
title_sort adjustable maintenance dosing with budesonide formoterol reduces asthma exacerbations compared with traditional fixed dosing a five month multicentre canadian study
url http://dx.doi.org/10.1155/2003/298039
work_keys_str_mv AT jmarkfitzgerlad adjustablemaintenancedosingwithbudesonideformoterolreducesasthmaexacerbationscomparedwithtraditionalfixeddosingafivemonthmulticentrecanadianstudy
AT malcolmrsears adjustablemaintenancedosingwithbudesonideformoterolreducesasthmaexacerbationscomparedwithtraditionalfixeddosingafivemonthmulticentrecanadianstudy
AT louisphilippeboulet adjustablemaintenancedosingwithbudesonideformoterolreducesasthmaexacerbationscomparedwithtraditionalfixeddosingafivemonthmulticentrecanadianstudy
AT allanbbecker adjustablemaintenancedosingwithbudesonideformoterolreducesasthmaexacerbationscomparedwithtraditionalfixeddosingafivemonthmulticentrecanadianstudy
AT andrewrmcivor adjustablemaintenancedosingwithbudesonideformoterolreducesasthmaexacerbationscomparedwithtraditionalfixeddosingafivemonthmulticentrecanadianstudy
AT pierreernst adjustablemaintenancedosingwithbudesonideformoterolreducesasthmaexacerbationscomparedwithtraditionalfixeddosingafivemonthmulticentrecanadianstudy
AT natashamsmiljanicgeorgijev adjustablemaintenancedosingwithbudesonideformoterolreducesasthmaexacerbationscomparedwithtraditionalfixeddosingafivemonthmulticentrecanadianstudy
AT joannasmlee adjustablemaintenancedosingwithbudesonideformoterolreducesasthmaexacerbationscomparedwithtraditionalfixeddosingafivemonthmulticentrecanadianstudy